Lactic acidosis and developmental delay due to deficiency of E3 binding protein (protein X) of the pyruvate dehydrogenase complex

2004 ◽  
Vol 27 (4) ◽  
pp. 477-485 ◽  
Author(s):  
D. G. Ramadan ◽  
R. A. Head ◽  
A. Al-Tawari ◽  
Y. Habeeb ◽  
M. Zaki ◽  
...  
1993 ◽  
Vol 123 (6) ◽  
pp. 915-920 ◽  
Author(s):  
C. Marsac ◽  
D. Stansbie ◽  
G. Bonne ◽  
J. Cousin ◽  
P. Jehenson ◽  
...  

Author(s):  
Dhivya Venkatesan ◽  
Sunil Kumar Samal ◽  
Ashwini Vishalakshi ◽  
Pallavee P. ◽  
Prabh C. S.

Pyruvate dehydrogenase complex deficiency is an inherited inborn error of metabolism causing lactic acidosis and several neurological symptoms. Its incidence and prevalence are not known. Here we report about a child with global developmental delay, central hypotonia and dyskinesia. Sanger sequencing was done and found to have homozygous nonsense mutation in exon 4 of PDHX gene causing lactic acidosis. In the next pregnancy selective Sanger variant analysis was carried out and the fetus was also found to be affected with the same genetic defect. Hence medical termination of Pregnancy was carried out. We conclude that early selective genetic testing will prevent further affected births.


Author(s):  
Mirian C. H. Janssen ◽  
Shamima Rahman

Pyruvate dehydrogenase complex (PDHc) deficiency usually first manifests at a young age and is rarely diagnosed in adulthood. The clinical picture varies from neonatal death with overwhelming lactic acidosis to a relatively benign course early in life. The three main presentations are congenital lactic acidosis, Leigh syndrome, and episodic ataxia. Treatment consists of a ketogenic diet and cofactor supplementation with thiamine. Successful therapy is rare.


2007 ◽  
Vol 283 (3) ◽  
pp. 1670-1678 ◽  
Author(s):  
Shawn C. Burgess ◽  
Katsumi Iizuka ◽  
Nam Ho Jeoung ◽  
Robert A. Harris ◽  
Yoshihiro Kashiwaya ◽  
...  

Livers from mice lacking the carbohydrate-responsive element-binding protein (ChREBP) were compared with wild type (WT) mice to determine the effect of this transcription factor on hepatic energy metabolism. The pyruvate dehydrogenase complex was considerably more active in ChREBP-/- mice because of diminished pyruvate dehydrogenase kinase activity. Greater pyruvate dehydrogenase complex activity caused a stimulation of lactate and pyruvate oxidation, and it significantly impaired fatty acid oxidation in perfused livers from ChREBP-/- mice. This shift in mitochondrial substrate utilization led to a 3-fold reduction of the free cytosolic [NAD+]/[NADH] ratio, a 1.7-fold increase in the free mitochondrial [NAD+]/[NADH] ratio, and a 2-fold decrease in the free cytosolic [ATP]/[ADP][Pi] ratio in the ChREBP-/- liver compared with control. Hepatic pyruvate carboxylase flux was impaired with ChREBP deletion secondary to decreased fatty acid oxidation, increased pyruvate oxidation, and limited pyruvate availability because of reduced activity of liver pyruvate kinase and malic enzyme, which replenish pyruvate via glycolysis and pyruvate cycling. Overall, the shift from fat utilization to pyruvate and lactate utilization resulted in a decrease in the energy of ATP hydrolysis and a hypo-energetic state in the livers of ChREBP-/- mice.


1989 ◽  
Vol 160 (2) ◽  
pp. 715-721 ◽  
Author(s):  
Subramanian Gopalakrishnan ◽  
Mohammed Rahmatullah ◽  
Gary A. Radke ◽  
Susan Powers-Greenwood ◽  
Thomas E. Roche

Sign in / Sign up

Export Citation Format

Share Document